-
Q&A with Australian Health Practitioners
Different treatment for Ulcerative Colitis and Crohns why?
Related Topics
I have been diagnosed with 90% ulcerative colitis and possiblity 10% crohns and because of this I am being treated for Ulcerative Colitis. But I found some treatment to treat Crohns disease is impossible to get treated for UC like infliximab and humira. Can someone explain why especially when I read other countries use these for treatment for UC and crohns. -
Find a professional to answer your question
Find a professional to answer your question Search Now
-
1
Agree
For more than 25 years, Crohn’s & Colitis Australia™ (formerly the Australian Crohn’s and Colitis Association) has been making life more liveable for more than … View Profile
A small percentage of people fall into a category where it is not possible to know for sure whether it is Crohn's affecting their colon or if it is ulcerative colitis (UC). The term used to describe this is IBDU, which is IBD unclassified. Sometimes it is referred to as indeterminate colitis. It's likely that at the time of your diagnosis all the characteristics and pathology leaned mostly towards UC, but this could change over time where it will be possible to differentiate if you have CD or UC. Treatments such as infliximab or adalimumab (Humira) are able to be used for both conditions, which means they have been approved by the Therapeutic Goods Administration (TGA) for use in Crohn's as well as ulcerative colitis, however at this stage they are only listed on the Pharmaceutical Benefits Scheme (PBS) for those who have Crohn's disease and meet a certain criteria in order to be eligible for these subsidised treatments. In some circumstances ulcerative colitis patients deemed in need can receive these treatments under special arrangement. It is hoped that one day these treatments will be added to the PBS for use in UC.
Report this post
You must be a HealthShare member to report this post. to your account or now (it's free).
